THE ARABIC LUPUSPRO: CROSS-CULTURAL VALIDATION OF A DISEASE-SPECIFIC PATIENT-REPORTED OUTCOME TOOL FOR QUALITY OF LIFE IN LUPUS PATIENTS

被引：0
|
作者：
Elkaraly, N. E. [1 ]
Nasef, S. I. [1 ]
Omar, A. S. [1 ]
Fouad, A. M. [2 ]
Meenakshi, J. [3 ]
Mohamed, A. E. [1 ]
机构：
[1] Suez Canal Univ, Fac Med, Phys Med Rheumatol & Rehabil, Ismailia, Egypt
[2] Suez Canal Univ, Fac Med, Publ Hlth Occupat & Environm Med, Ismailia, Egypt
[3] Rush Univ, Med & Behav Sci, Chicago, IL 60612 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.4042
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1238
引用
收藏
页码：1905 / 1906
页数：2
相关论文
共 50 条
  • [1] The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients
    Elkaraly, Nourhan Elameen
    Nasef, Samah Ismail
    Omar, Aziza Sayed
    Fouad, Ahmed Mahmoud
    Jolly, Meenakshi
    Mohamed, Aly Elsayed
    LUPUS, 2020, 29 (13) : 1727 - 1735
  • [2] Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines
    Navarra, S. V.
    Tanangunan, R. M. D. V.
    Mikolaitis-Preuss, R. A.
    Kosinski, M.
    Block, J. A.
    Jolly, M.
    LUPUS, 2013, 22 (03) : 262 - 267
  • [3] Validation of the French Version of Lupus Patient Reported Outcome (LupusPRO), a Disease-Specific Patient Reported Outcome for Lupus Patients
    Devilliers, Herve
    Jolly, Meenakshi
    Samson, Maxime
    Bonnotte, Bernard
    Maurier, Francois
    Seve, Pascal
    Magy-Bertrand, Nadine
    Wahl, Denis
    Pennaforte, Jean-Loup
    Martin, Thierry
    Aumaitre, Olivier
    Blaison, Gilles
    Bielefeld, Philip
    Mathian, Alexis
    Binquet, Christine
    Amoura, Zahir
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [4] Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus
    Azizoddin, D. R.
    Weinberg, S.
    Gandhi, N.
    Arora, S.
    Block, J. A.
    Sequeira, W.
    Jolly, M.
    LUPUS, 2018, 27 (05) : 728 - 737
  • [5] Cross-cultural Validation of a Disease-specific Patient-reported Outcome Measure for Systemic Lupus Erythematosus in Canada
    Bourre-Tessier, Josiane
    Clarke, Ann E.
    Mikolaitis-Preuss, Rachel A.
    Kosinski, Mark
    Bernatsky, Sasha
    Block, Joel A.
    Jolly, Meenakshi
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (08) : 1327 - 1333
  • [6] Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus
    Pinto, B.
    Jolly, M.
    Dhooria, A.
    Grover, S.
    Raj, J. M.
    Devilliers, H.
    Sharma, A.
    LUPUS, 2019, 28 (13) : 1534 - 1540
  • [7] VALIDATION OF A DISEASE-SPECIFIC PATIENT-REPORTED OUTCOME MEASURE FOR ARABIC PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    El Miedany, Y.
    El Gaafary, M.
    Sayed, S.
    Ahmed, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 189 - 189
  • [8] The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus
    Inoue, M.
    Shiozawa, K.
    Yoshihara, R.
    Yamane, T.
    Shima, Y.
    Hirano, T.
    Jolly, M.
    Makimoto, K.
    LUPUS, 2017, 26 (08) : 849 - 856
  • [9] The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus
    Bourre-Tessier, J.
    Clarke, A. E.
    Kosinski, M.
    Mikolaitis-Preuss, R. A.
    Bernatsky, S.
    Block, J. A.
    Jolly, M.
    LUPUS, 2014, 23 (14) : 1452 - 1459
  • [10] Cross-cultural adaptation and validation of a patient-reported hip outcome score
    Haragus, Horia
    Prejbeanu, Radu
    Poenaru, Dan V.
    Deleanu, Bogdan
    Timar, Bogdan
    Vermesan, Dinu
    INTERNATIONAL ORTHOPAEDICS, 2018, 42 (05) : 1001 - 1006
12345